Unilever Nigeria Plc (NGX:UNILEVER)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions NGN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	428,003	189,298	85,026	66,642	83,303	79,856
Market Cap Growth	129.55%	122.64%	27.59%	-20.00%	4.32%	-36.82%
Enterprise Value	345,814	140,486	18,067	13,411	34,807	46,813
Last Close Price	74.50	31.97	13.65	10.49	12.59	12.07
PE Ratio	17.01	12.50	10.07	14.92	24.44	-
Forward PE	13.09	10.70	19.04	57.12	83.14	-
PS Ratio	2.33	1.27	0.82	0.97	1.18	1.53
PB Ratio	4.64	2.22	1.14	0.99	1.27	1.29
P/TBV Ratio	4.64	2.22	1.14	0.99	1.27	1.29
P/FCF Ratio	10.22	22.26	-	6.37	4.51	58.96
P/OCF Ratio	8.96	13.01	-	5.54	4.15	33.26
PEG Ratio	0.32	1.69	1.69	1.69	1.69	1.69
EV/Sales Ratio	1.88	0.94	0.17	0.20	0.49	0.90
EV/EBITDA Ratio	9.29	6.84	0.79	1.24	6.76	29.67
EV/EBIT Ratio	10.05	7.75	0.90	1.60	18.68	-
EV/FCF Ratio	8.25	16.52	-	1.28	1.89	34.56
Debt / Equity Ratio	0.04	0.07	0.05	0.20	0.11	0.00
Debt / EBITDA Ratio	0.12	0.30	0.16	1.26	1.31	0.12
Debt / FCF Ratio	0.10	0.74	-	1.30	0.38	0.18
Asset Turnover	1.17	1.16	0.86	0.59	0.71	0.54
Inventory Turnover	2.37	2.82	3.20	2.69	3.51	3.22
Quick Ratio	1.57	1.48	2.03	1.37	1.70	1.56
Current Ratio	2.28	2.29	2.84	1.88	2.14	2.30
Return on Equity (ROE)	20.58%	18.98%	23.11%	8.07%	1.08%	-5.84%
Return on Assets (ROA)	11.38%	8.79%	10.40%	4.47%	1.17%	-2.05%
Return on Capital (ROIC)	18.18%	13.38%	15.79%	6.79%	1.72%	-3.09%
Return on Capital Employed (ROCE)	26.10%	20.00%	24.40%	11.90%	2.70%	-
Earnings Yield	5.87%	8.00%	9.93%	6.70%	4.09%	-4.97%
FCF Yield	9.79%	4.49%	-7.27%	15.70%	22.17%	1.70%
Dividend Yield	1.72%	3.91%	5.50%	2.38%	3.97%	-
Payout Ratio	30.30%	28.45%	72.70%	13.96%	1.63%	-
Buyback Yield / Dilution	1.72%	-	-	-	-	-
Total Shareholder Return	3.44%	3.91%	5.50%	2.38%	3.97%	-

Updated Jan 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.